Celsion Corp (CLSN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Celsion Corp (CLSN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013815
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Celsion Corp (Celsion) is an oncology company that focuses on developing a portfolio of new cancer treatments, including directed chemotherapies, RNA based therapies and DNA-mediated immunotherapy. The company’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), TheraPlas and TheraSilence provide the foundation for a wide range of therapeutics for common and difficult-to-treat forms of cancers. Its lead product candidate ThermoDox is a proprietary dosage form of doxorubicin based LTSL technology in a Phase III clinical trial for the treatment of non-resectable hepatocellular carcinoma (HCC) and a Phase II clinical trial for recurrent chest wall (RCW) breast cancer. It is also developing a comprehensive pipeline of targeted therapeutic agents. Celsion is headquartered in Lawrenceville, New Jersey, the US.

Celsion Corp (CLSN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Celsion Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Celsion Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Celsion Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Celsion Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Celsion Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Celsion Corp, Medical Equipment, Deal Details 10
Equity Offering 10
Celsion Plans to Raise up to USD7.4 Million in Private Placement of Shares up on Exercise of Warrants 10
Celsion Prices Public Offering of Shares for USD6.6 Million 12
Celsion Plans to Raise Funds through Private Placement of Shares up on Exercise of Warrants 13
Celsion to Raise up to USD2.4 Million in Public Offering of Shares 14
Celsion Raises USD5 Million in Public Offering of Shares and Warrants 15
Celsion Raises USD1.8 Million in Private Placement of Shares and Warrants 16
Celsion Raises USD6 Million in Private Placement of Shares 17
Celsion Raises USD8 Million in Private Placement of Shares 18
Celsion Announces Private Placement Of Common Stock For US$15 Million 19
Celsion Completes Registered Direct Offering Of Units For US$13 Million 20
Celsion Completes Registered Direct Offering Of Units For US$5.6 Million 21
Celsion Corp – Key Competitors 22
Celsion Corp – Key Employees 23
Celsion Corp – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Financial Announcements 25
Nov 14, 2017: Celsion Reports Third Quarter 2017 Financial Results and Provides Business Update 25
Aug 15, 2017: Celsion Reports Second Quarter 2017 Financial Results and Provides Business Update 28
May 12, 2017: Celsion Reports First Quarter 2017 Financial Results and Provides Business Update 31
Mar 16, 2017: Celsion Reports Year End 2016 Financial Results and Provides Business Update 33
Nov 10, 2016: Celsion Reports Third Quarter 2016 Financial Results 35
Aug 15, 2016: Celsion Reports Second Quarter 2016 Financial Results and Provides Business Update 37
May 16, 2016: Celsion Reports First Quarter 2016 Financial Results and Provides Business Update 39
Mar 30, 2016: Celsion Reports Year End 2015 Financial Results and Provides Business Update 41
Legal and Regulatory 43
Aug 04, 2017: Celsion to Delist from the Tel Aviv Stock Exchange 43
Product News 44
03/07/2016: Celsion Announces Launch of the OPTIMA Study in China 44
03/01/2016: Celsion Corporation Announces Issuance of Key U.S. Patent Covering its Novel TheraSilence RNA Program 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Celsion Corp, Medical Equipment, Key Facts, 2016 2
Celsion Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Celsion Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Celsion Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Celsion Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Celsion Corp, Deals By Market, 2011 to YTD 2017 8
Celsion Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Celsion Plans to Raise up to USD7.4 Million in Private Placement of Shares up on Exercise of Warrants 10
Celsion Prices Public Offering of Shares for USD6.6 Million 12
Celsion Plans to Raise Funds through Private Placement of Shares up on Exercise of Warrants 13
Celsion to Raise up to USD2.4 Million in Public Offering of Shares 14
Celsion Raises USD5 Million in Public Offering of Shares and Warrants 15
Celsion Raises USD1.8 Million in Private Placement of Shares and Warrants 16
Celsion Raises USD6 Million in Private Placement of Shares 17
Celsion Raises USD8 Million in Private Placement of Shares 18
Celsion Announces Private Placement Of Common Stock For US$15 Million 19
Celsion Completes Registered Direct Offering Of Units For US$13 Million 20
Celsion Completes Registered Direct Offering Of Units For US$5.6 Million 21
Celsion Corp, Key Competitors 22
Celsion Corp, Key Employees 23

★海外企業調査レポート[Celsion Corp (CLSN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Spectrum Pharmaceuticals Inc (SPPI):企業の財務・戦略的SWOT分析
    Spectrum Pharmaceuticals Inc (SPPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • InBios International Inc:企業の製品パイプライン分析
    Summary InBios International Inc (InBios International) is a medical device company that develops, manufactures and markets medical diagnostic tests for detecting infectious diseases. The company offers products such as assays, ELISA kits, rapid immunoassays, veterinary products, and monoclonal anti …
  • Bimini Capital Management, Inc.:企業の戦略・SWOT・財務情報
    Bimini Capital Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bimini Capital Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • The Greenbrier Companies, Inc.:企業の戦略・SWOT・財務分析
    The Greenbrier Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Greenbrier Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • ZincX Resources Corp.:企業の戦略・SWOT・財務情報
    ZincX Resources Corp. - Strategy, SWOT and Corporate Finance Report Summary ZincX Resources Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • GenomeDx Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary GenomeDx Biosciences Inc (GenomeDx) is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. The company offers decipher prostate cancer classifier, a transformative genomic test that provides an assessment of tumor agg …
  • Dil Ltd (506414):企業の財務・戦略的SWOT分析
    Summary Dil Ltd (Dil), formerly Duphar-Interfran Ltd, is a developer of medicinal and pharmaceutical products. The company offers products in the areas such as biotechnology, environmental solutions, pharmaceuticals, and vitamins. It also offers services such as health and wellness, entertainment, e …
  • HSE Integrated Ltd:企業の戦略的SWOT分析
    HSE Integrated Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • H. Butting GmbH & Co KG:企業の戦略・SWOT・財務情報
    H. Butting GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary H. Butting GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • CareDx Inc (CDNA):企業の製品パイプライン分析2018
    Summary CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used …
  • NextEra Energy, Inc.:企業の戦略・SWOT・財務情報
    NextEra Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary NextEra Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • China Power Clean Energy Development Co Ltd (0735):企業の財務・戦略的SWOT分析
    China Power Clean Energy Development Co Ltd (0735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • BDO International Limited:戦略・SWOT・企業財務分析
    BDO International Limited - Strategy, SWOT and Corporate Finance Report Summary BDO International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • George Weston Limited (WN):企業の財務・戦略的SWOT分析
    George Weston Limited (WN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Daisy IT Group Ltd:企業の戦略的SWOT分析
    Daisy IT Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Amarantus Bioscience Holdings Inc (AMBS):企業の財務・戦略的SWOT分析
    Summary Amarantus Bioscience Holdings Inc (Amarantus), formerly Amarantus BioSciences Inc, is a biotechnology company that discovers and develops treatments for various therapeutic diseases. The company’s pipeline products comprise eltoprazine and mesencephalic-astrocyte-derived neurotrophic factor. …
  • Exact Sciences Corp (EXAS):製品パイプライン分析
    Summary Exact Sciences Corp (Exact) is a molecular diagnostic company that focuses on the early detection and prevention of various cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of …
  • Pierrel Spa (PRL):製薬・医療:M&Aディール及び事業提携情報
    Summary Pierrel Spa (Pierrel) is a pharmaceutical company that offers contract services to biopharmaceutical and life sciences industries across the world. The company offers services in the areas of contract research, discovery of medicinal product candidates, clinical research and contract manufac …
  • Zeria Pharmaceutical Co Ltd (4559):製薬・医療:M&Aディール及び事業提携情報
    Summary Zeria Pharmaceutical Co Ltd (Zeria), formerly Zeria Yakusho Kenkyusho Co Ltd is a pharmaceutical company that manufactures pharmaceutical and non-pharmaceuticals, veterinary pharmaceuticals, industrial chemicals and reagents. The company imports and exports healthcare products such as cosmet …
  • Hermes International SA:企業の戦略・SWOT・財務分析
    Hermes International SA - Strategy, SWOT and Corporate Finance Report Summary Hermes International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆